-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Characterizing Dead-Box ATP-Dependent RNA Helicase 41 (DDX41) Germline Variants in Hereditary Myeloid Neoplasms

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: DDX41-Mediated Malignancies
Friday, December 6, 2024, 2:41 PM-3:25 PM

Kirsten Gronbaek, MD, PhD, PR

Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark; Rigshospitalet, University of Copenhagen, Kirsten Grønbæk, Copenhagen N, Denmark

Disclosures: Gronbaek: Janssen: Research Funding; Otsuka Pharma: Membership on an entity's Board of Directors or advisory committees.